Elsevier

Journal of Hepatology

Volume 54, Issue 2, February 2011, Pages 265-271
Journal of Hepatology

Research Article
Acute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patients

https://doi.org/10.1016/j.jhep.2010.06.042Get rights and content

Background & Aims

Transjugular intrahepatic stent-shunt (TIPSS) insertion, in patients with uncontrolled gastro-intestinal bleeding, often results in worsening of the systemic hemodynamics which can be associated with intracranial hypertension but the underlying mechanisms are unclear. This study explored the hypothesis that TIPSS insertion results in acute endotoxemia which is associated with increased nitric oxide production resulting in systemic and cerebral vasodilatation.

Methods

Twelve patients with cirrhosis who were undergoing TIPSS for uncontrolled variceal bleeding were studied prior to and 1-h after TIPSS insertion. Changes in cardiac output (CO) and cerebral blood flow (CBF) were measured. NO production was measured using stable isotopes using l-[guanidino-15N2] arginine and l-[ureido-13C;5,5-2H2] citrulline infusion. The effect of pre- and post-TIPSS plasma on nitric oxide synthase (NOS) activity on human endothelial cell-line (HUVEC) was measured.

Results

TIPSS insertion resulted in a significant increase in CO and CBF. Endotoxin and induced neutrophil oxidative burst increased significantly without any significant changes in cytokines. Whole body NO production increased significantly and this was associated with increased iNOS activity in the HUVEC lines. The change in NO production correlated with the changes in CO and CBF. Brain flux of ammonia increased without significant changes in arterial ammonia.

Conclusions

In conclusion, the insertion of TIPSS results in acute endotoxemia which is associated with increased nitric oxide production possibly through an iNOS dependent mechanism which may have important pathophysiological and therapeutic relevance to understanding the basis of circulatory failure in the critically ill cirrhotic patient.

Introduction

Acute decompensation of cirrhosis due to a precipitating illness often progresses to acute systemic hypotension which may also be associated with severe hepatic encephalopathy and multi-organ failure, as well as with high mortality rates. Moreover, these symptoms are difficult to distinguish clinically from acute liver failure, a condition often referred to as acute-on-chronic liver failure (ACLF) [1]. A small proportion of patients develops overt intracranial hypertension [2], [3]. Previous studies have shown that TIPSS results in increased cardiac output (CO) and a reduction in systemic vascular resistance (SVR) and mean arterial pressure (MAP) [4], [5]. We have previously reported deaths in four patients due to brain herniation from intracranial hypertension following insertion of a transjugular intrahepatic portosystemic stent-shunt (TIPSS) [2], [3]. These patients had advanced liver disease, uncontrolled variceal bleeding, sepsis, and renal failure. The TIPSS procedure may provide the opportunity to study the hemodynamic effects of acute portacaval shunting in patients with cirrhosis and provide clues to factors important in the pathogenesis of circulatory collapse and the hepatic encephalopathy components of ACLF.

Recent studies also point to an important role of the systemic inflammatory response in the pathogenesis of ACLF and the associated hepatic encephalopathy [6], [7], [8]. Our recent studies have suggested that patients with severe alcoholic hepatitis who progress to ACLF have markedly altered neutrophil function which is possibly mediated through high circulating endotoxin levels. Endotoxin is not only a priming agent but can also fully activate neutrophils [9], [10], [11], probably by up-regulating the NADPH oxidase assembly [11]. The highest levels of endotoxin reported in patients with liver disease are found in portal venous blood [12], [13], highlighting the importance of the bowel and altered gut permeability as the possible source of endotoxin [14]. Hence, it would be reasonable to expect that TIPSS insertion may exacerbate the existing endotoxemia which is known to induce iNOS in endothelial cells.

The aims of the present study were, therefore, to test the hypothesis that TIPSS worsens endotoxemia which increases nitric oxide production resulting in acute systemic and cerebral changes. In endothelial cell culture systems, we also wanted to determine whether incubation of the cells with patient’s plasma would alter the activity of nitric oxide synthase.

Section snippets

Methods

Studies were undertaken with the approval of the local research ethics committee, written informed consent was obtained from the next of kin of each patient, and were in accordance with the Declaration of Helsinki (1951) of the World Medical Association.

Results

Twelve patients were enrolled into the study. In two patients, placement of a reverse jugular vein catheter was not possible for technical reasons. In one other patient, the measurement of CBF failed due to technical difficulties with the automatic sampler and the mean value of CBF from the whole group was used for calculation of the brain flux in this patient. The present paper, therefore, reports the systemic data obtained from all the 12 patients but CBF data from nine patients and brain

Discussion

The most important result of our study was the observation of acute systemic and cerebral vasodilatation which was closely correlated with an increase in whole body nitric oxide production after TIPSS insertion. This resulted in exacerbation of endotoxemia and in whole body NO production but not in the arterial or brain flux of pro-inflammatory cytokines. The ex vivo experiments suggested that this increase in the rate of production of nitric oxide was associated with an increase in the

Disclaimer

The data presented in this paper are original. The only data that overlap with the previous paper are the ammonia data. Other observations from the patients described in this paper have been described before in ‘Olde Damink et al. Am J Physiol Gastrointest Liver Physiol’ and ‘Olde Damink et al. 2006;291(2):G189–94. Hepatology 2003;37(6):1277–85.’

Acknowledgements

We acknowledge gratefully the co-operation of all the medical and non-medical staff in the Intensive Care Unit of the Royal Infirmary of Edinburgh and also Dr. Stuart McLennan for help with the successful completion of the studies. We also acknowledge the contribution of Dr. V. Balasubramanium and Dr. Dipok Dhar who kindly performed the ex-vivo studies measuring NOS activity in HUVEC cell-line. Dr. Steven W.M. Olde Damink was supported on a grant from the Wellcome Trust (UK).

References (44)

  • R.P. Mookerjee et al.

    Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis

    Gastroenterology

    (2007)
  • R. Wiest et al.

    The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough

    Hepatology

    (2002)
  • A. Helmy et al.

    Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis

    J Hepatol

    (2003)
  • G. La Villa et al.

    Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis

    Hepatology

    (2001)
  • J. Cordoba et al.

    Mild hypothermia modifies ammonia-induced brain edema in rats after portacaval anastomosis

    Gastroenterology

    (1999)
  • F.S. Larsen et al.

    Cerebral hyperemia and nitric oxide synthase in rats with ammonia-induced brain edema

    J Hepatol

    (2001)
  • R. Jalan et al.

    Acute-on-chronic liver failure: pathophysiological basis of therapeutic options

    Blood Purif

    (2002)
  • D. Azoulay et al.

    Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study

    Hepatology

    (1994)
  • E. Lotterer et al.

    Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis

    Hepatology

    (1999)
  • R.H. Bohmer et al.

    Dose effects of LPS on neutrophils in a whole blood flow cytometric assay of phagocytosis and oxidative burst

    Cytometry

    (1992)
  • F.R. DeLeo et al.

    Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly

    J Clin Invest

    (1998)
  • H. Prytz et al.

    Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis

    Scand J Gastroenterol

    (1976)
  • Cited by (32)

    • Cerebral Blood Flow and Metabolism in Hepatic Encephalopathy—A Meta-Analysis

      2018, Journal of Clinical and Experimental Hepatology
    • A pilot study of a non-invasive oral nitrate stable isotopic method suggests that arginine and citrulline supplementation increases whole-body NO production in Tanzanian children with sickle cell disease

      2018, Nitric Oxide - Biology and Chemistry
      Citation Excerpt :

      A lower systemic NO synthesis was also measured in ten critically ill children with sepsis (NO synthesis rate = 1.58 ± 0.7 μmol/kg/h) and differences with our study could be related to disease pathogenesis and/or characteristics of the stable isotope methods [11]. However, two studies found similar (2.4 ± 0.6 μmol/kg/h) [12] or higher (4.3 ± 2.7 μmol/kg/h) [13] NO synthesis rates in adult patients with cirrhosis and end stage renal disease, respectively, using isotopic methods based on the intravenous administration of labelled arginine. There is currently limited information on the NO synthesis rates in pediatric populations.

    • Inflammation and portal hypertension - The undiscovered country

      2014, Journal of Hepatology
      Citation Excerpt :

      There is indirect evidence in humans for gut-derived bacteria exacerbating systemic circulatory dysfunction in cirrhosis. Patients with advanced cirrhosis demonstrate increased systemic NO production and endotoxinemia following TIPS insertion [62]. Plasma from these patients, when incubated with HUVEC cells, leads to decreased eNOS activity but increased iNOS activity, suggesting that portal venous bacterial products cause increased systemic NO production and circulatory dysfunction.

    • Changes in cerebral blood flow after transjugular intrahepatic portosystemic shunt can help predict the development of hepatic encephalopathy: An arterial spin labeling MR study

      2012, European Journal of Radiology
      Citation Excerpt :

      On the one hand, increased CBFs were found widely in the brain regions and over half of cirrhotic patients (66.7%, 6/9) following TIPS were of global increased CBFs. These findings were consistent with the previous reports on patients after TIPS [8]. Also, our results were similar with measurements of patients after portacaval shunt operation [5] and rats with portacaval shunt-induced hyperammonemia [17], in which CBFs were reported to increase.

    • Acute-on chronic liver failure

      2012, Journal of Hepatology
      Citation Excerpt :

      In a recent study, the acute effect of insertion of a transjugular intrahepatic shunt, which is known to induce endotoxemia, was studied in patients with cirrhosis. The study demonstrated that TIPSS-induced endotoxemia led to an increase in the rate of production of nitric oxide, which was associated with endothelial dysfunction and increased cerebral blood flow supporting the hypothesis that multiple hits and brain swelling is a feature of ACLF [115] (Fig. 5). However, the insertion of TIPSS in relatively well cirrhotics without hepatic encephalopathy undergoing TIPSS was not associated with a change in cerebral blood flow, stressing the pathophysiologically distinct nature of ACLF from otherwise stable cirrhosis [116].

    View all citing articles on Scopus
    View full text